Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Breccia

Showing results (41-50 of 427) with videos related to

Pageof 43
Sort By:
International Journal of Hematologic Oncology|October 11, 2018
Current first- and second-line treatment options in acute promyelocytic leukemiaFulvio Massaro, Matteo Molica, Massimo Breccia
Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana Alimena
Expert Review of Molecular Diagnostics|September 21, 2017
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an updateMatteo Molica, Fulvio Massaro, Massimo Breccia
Critical Reviews in Oncology/Hematology|January 28, 2012
Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety dataMassimo Breccia, Mario Tiribelli, Giuliana Alimena
Leukemia Research|December 3, 2014
How tyrosine kinase inhibitors impair metabolism and endocrine system function: a systematic updated reviewMassimo Breccia, Matteo Molica, Giuliana Alimena
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Management of acute promyelocytic leukemia in the elderlyFrancesco Lo-Coco, Roberto Latagliata, Massimo Breccia
Expert Review of Anticancer Therapy|September 28, 2020
On the road to treatment-free remission in chronic myeloid leukemia: what about 'the others'?Fabio Stagno, Massimo Breccia, Francesco Di Raimondo
British Journal of Haematology|December 22, 2015
Current standard treatment of adult acute promyelocytic leukaemiaFrancesco Lo-Coco, Laura Cicconi, Massimo Breccia
Best Practice & Research. Clinical Haematology|August 26, 2003
The importance of molecular monitoring in acute promyelocytic leukaemiaFrancesco Lo-Coco, Massimo Breccia, Daniela Diverio
Drugs of Today (Barcelona, Spain : 1998)|October 28, 2022
Asciminib in chronic myeloid leukemiaGiovanni Manfredi Assanto, Emilia Scalzulli, Massimo Breccia
Pageof 43

Showing results (41-50 of 427) with videos related to

Sort By:
Pageof 43
International Journal of Hematologic Oncology|October 11, 2018
Current first- and second-line treatment options in acute promyelocytic leukemiaFulvio Massaro, Matteo Molica, Massimo Breccia
Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana Alimena
Expert Review of Molecular Diagnostics|September 21, 2017
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an updateMatteo Molica, Fulvio Massaro, Massimo Breccia
Critical Reviews in Oncology/Hematology|January 28, 2012
Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety dataMassimo Breccia, Mario Tiribelli, Giuliana Alimena
Leukemia Research|December 3, 2014
How tyrosine kinase inhibitors impair metabolism and endocrine system function: a systematic updated reviewMassimo Breccia, Matteo Molica, Giuliana Alimena
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Management of acute promyelocytic leukemia in the elderlyFrancesco Lo-Coco, Roberto Latagliata, Massimo Breccia
Expert Review of Anticancer Therapy|September 28, 2020
On the road to treatment-free remission in chronic myeloid leukemia: what about 'the others'?Fabio Stagno, Massimo Breccia, Francesco Di Raimondo
British Journal of Haematology|December 22, 2015
Current standard treatment of adult acute promyelocytic leukaemiaFrancesco Lo-Coco, Laura Cicconi, Massimo Breccia
Best Practice & Research. Clinical Haematology|August 26, 2003
The importance of molecular monitoring in acute promyelocytic leukaemiaFrancesco Lo-Coco, Massimo Breccia, Daniela Diverio
Drugs of Today (Barcelona, Spain : 1998)|October 28, 2022
Asciminib in chronic myeloid leukemiaGiovanni Manfredi Assanto, Emilia Scalzulli, Massimo Breccia
Pageof 43